Antigenic proteins of Helicobacter pylori of potential diagnostic value

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1635-1642

  Khalilpour, Akbar ^a   Santhanam, Amutha ^a   Wei, Lee Chun ^a   Saadatnia, Geita ^a,b   Velusamy, Nagarajan ^c   Osman, Sabariah ^a   Mohamad, Ahmad Munir ^a   Noordin, Rahmah ^a  

^a INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

^b IRANIAN RESEARCH ORGANIZATION FOR SCIENCE AND TECHNOLOGY IROST   (Iran)

^c Seberang Jaya Hospital   (Malaysia)

Author keywords

2 DE; Helicobacter pylori; Mass; Potential infection markers; Spectrometry; Western blot

Indexed keywords

EID: 84880442313     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1635     Document Type: Article

References (91)

1. Andersen LP, Espersen F (1992). Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol, 30, 1743-51.
2. Alam J, Maiti S, Ghosh P, et al (2012). Significant association of the dupA gene of Helicobacter pylori with duodenal ulcer development in a South-east Indian population. J Med Microbiol, 61, 1295-302.
3. Baik SC, Kim KM, Song SM, et al (2004). Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Helicobacter pylori strain 26695. J Bacteriol, 186, 949-55.
4. Benoit S, Mehta N, Wang G, Gatlin M, Maier RJ (2004). Requirement of hydD, hydE, hypC and hypE genes for hydrogenase activity in Helicobacter pylori. Microb Pathog, 36, 153-7.
5. Bergey B MP, Peacock J, Megraud F (2003). What is the role of serology in assessing Helicobacter pylori eradication. Alimentary pharmacology & therapeutics, 18, 635-9.
6. Besra GS, Kremer L, Nampoothiri KM, et al (2001). Biochemical characterization of acyl carrier protein (AcpM) and malonyl- CoA: AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biological Chemistry, 76, 27967-74.
7. Chan CH, Ko CC, Chang JG, et al (2006). Subcellular and functional proteomic analysis of the cellular responses induced by Helicobacter pylori. Mol Cell Proteomics, 4, 702-13.
8. Chambers MG, Pyburn TM, et al (2013). Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol, 425, 524-35.
9. Chisholm SA, Owen RJ (2008). Application of polymerase chain reaction-based assays for rapid identification and antibiotic resistance screening of Helicobacter pylori in gastric biopsies. Diagn Microbiol Infect Dis, 61, 67-71.
10. Chomvarin C, Ottiwet O, Hahnvajanawong C, Intapan PM, Wongwajana S (2009). Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Int J Infect Dis, 13, 647-54.
11. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI (1991). Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection. J Clin Pathology, 44, 326-8.
12. Cremonini F, Gabrielli M, Gasbarrini G, Pola P, Gasbarrini A (2004). The relationship between chronic H. pylori infection, CagA seropositivity and stroke: meta-analysis. Atherosclerosis, 173, 253-9.
13. Evans DJJ, Evans DG, Graham DY, Klein PD (1989). A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology, 96, 1004-8.
14. Flores-luna L, Camorlinga-Ponce M, Hernendez-Suarez G, et al (2013). The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries. Cancer Causes Control, 24, 241-8.
15. Faulde M, Putzker M, Mertes T, Sobe D (1991). Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori, and antigenic cross-reactivity between H. pylori and Campylobacter jejuni. J Clin Microbiol, 29, 323-7.
16. Franceschi F, Gasbarrini A (2007). Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol, 21, 325-34.
17. Galmiche A, Rassow J, Doye A, et al (2000). The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J, 19, 6361-70.
18. Ge R, Sun X, Gu Q, et al (2007). A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. J Biol Inorg Chem, 12, 831-42.
19. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI (2008). Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA, 105, 4358-63.
20. Glassman MS, Dallal S, Berezin SH, et al (1990). Helicobacter pylori-related gastroduodenal disease in children. Diagnostic utility of enzyme-linked immunosorbent assay. Dig Dis Sci, 35, 993-7.
21. Graham DY, Evans DJ, Jr, Peacock J, Baker JT, Schrier WH (1996). Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterology, 91, 942-8.
22. Haas G, Karaali G, Ebermayer K, et al (2002). Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics, 2, 313-24.
23. Hambers MG, Pyburn TM, Gonzalez-rivera C, et al (2013). Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol, 425, 524-35.
24. Inagaki E, Ohshima N, Takahashi H, et al (2006). Crystal structure of Thermus thermophilus Delta1-pyrroline-5- carboxylate dehydrogenase. J Mol Biol, 362, 490-501.
25. Jensen AKV, Andersen LP, Gaarslev K, Wachmann CH (1993). Comparison of four second generation kits for detection of IgG antibodies against Helicobacter pylori in adults. Zentralblatt für Bakteriologie, 280, 221-6.
26. Jiménez-Soto LF KS, Sewald X, Ertl C, et al (2009). Helicobacter pylori type IVsecretion apparatus exploits b1 integrin in anovel RGD-independent manner. PLoS Pathog, 5,1000684.
27. Jungblut PR, Bumann D, Haas G, et al (2000). Comparative proteome analysis of Helicobacter pylori. Mol Microbiol, 36,710-25.
28. Keenan J OJ, Domigan N, Potter H, et al (2000). Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun, 68, 3337-43.
29. Keenan J, Oliaro J, Domigan N, et al (2000). Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun, 68, 3337-43.
30. Khanna B, Cutler A, Israel NR, et al (1998). Use caution with serologic testing for Helicobacter pylori infection in children. J Infectious Diseases, 178, 460-5.
31. Krah A, Miehlke S, Pleissner KP, et al (2004). Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer, 108, 456-63.
32. Krah A MS, Pleissner KP, Zimny-Arndt U, et al (2004). Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. H. pylori Antigenic Proteins of Potential Diagnostic Value Cancer Causes Control, 24, 241-8.
33. Faulde M, Putzker M, Mertes T, Sobe D (1991). Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori, and antigenic cross-reactivity between H. pylori and Campylobacter jejuni. J Clin Microbiol, 29, 323-7.
34. Franceschi F, Gasbarrini A (2007). Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol, 21, 325-34.
35. Galmiche A, Rassow J, Doye A, et al (2000). The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J, 19, 6361-70.
36. Ge R, Sun X, Gu Q, et al (2007). A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori. J Biol Inorg Chem, 12, 831-42.
37. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI (2008). Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA, 105, 4358-63.
38. Glassman MS, Dallal S, Berezin SH, et al (1990). Helicobacter pylori-related gastroduodenal disease in children. Diagnostic utility of enzyme-linked immunosorbent assay. Dig Dis Sci, 35, 993-7.
39. Graham DY, Evans DJ, Jr, Peacock J, Baker JT, Schrier WH (1996). Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterology, 91, 942-8.
40. Haas G, Karaali G, Ebermayer K, et al (2002). Immunoproteomics of Helicobacter pylori infection and relation to gastric disease. Proteomics, 2, 313-24.
41. Hambers MG, Pyburn TM, Gonzalez-rivera C, et al (2013). Structural analysis of the oligomeric states of Helicobacter pylori VacA toxin. J Mol Biol, 425, 524-35.
42. Inagaki E, Ohshima N, Takahashi H, et al (2006). Crystal structure of Thermus thermophilus Delta1-pyrroline-5- carboxylate dehydrogenase. J Mol Biol, 362, 490-501.
43. Jensen AKV, Andersen LP, Gaarslev K, Wachmann CH (1993). Comparison of four second generation kits for detection of IgG antibodies against Helicobacter pylori in adults. Zentralblatt für Bakteriologie, 280, 221-6.
44. Jiménez-Soto LF KS, Sewald X, Ertl C, et al (2009). Helicobacter pylori type IVsecretion apparatus exploits b1 integrin in anovel RGD-independent manner. PLoS Pathog, 5,1000684.
45. Jungblut PR, Bumann D, Haas G, et al (2000). Comparative proteome analysis of Helicobacter pylori. Mol Microbiol, 36,710-25.
46. Keenan J OJ, Domigan N, Potter H, et al (2000). Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun, 68, 3337-43.
47. Keenan J, Oliaro J, Domigan N, et al (2000). Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immun, 68, 3337-43.
48. Khanna B, Cutler A, Israel NR, et al (1998). Use caution with serologic testing for Helicobacter pylori infection in children. J Infectious Diseases, 178, 460-5.
49. Krah A, Miehlke S, Pleissner KP, et al (2004). Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer, 108, 456-63.
50. Krah A MS, Pleissner KP, Zimny-Arndt U, et al (2004). Identification of candidate antigens for serologic detection of Helicobacter pylori-infected patients with gastric carcinoma. Int J Cancer, 108, 456-63.
51. Kwok T, Zabler D, Urman S, et al (2007). Helicobacter exploits integrin for type IV secretion and kinase activation. Nature, 449, 862-6.
52. Leung WK, Ng EKW, Chan FKL, Chung SCS, Sung JJY (1999). Evaluation of three commercial enzyme-linked immunosorbent assay kits for diagnosis of Helicobacter pylori in Chinese patients. Diagnostic Microbiology and Infectious Disease, 34, 13-17.
53. Lin Y-F, Chen C-Y, Tsai M-H, et al (2007). Duodenal ulcerrelated antigens from Helicobacter pylori. Immunoproteome and protein microarray approaches. Molecular and Cellular Proteomics, 6, 1018-26.
54. Lochhead P, El-Omar EM (2007). Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol, 21, 281-97.
55. Malaty HM (2007). Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol, 21, 205-14.
56. Manes G BA, Iaquinto G, Ricci C, et al (2001). Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy. Aliment Pharmacol Ther, 15, 73-9.
57. Manes G, Balzano A, Iaquinto G, et al (2001). Accuracy of stool antigen test in posteradication assessment of Helicobacter pylori infection. Dig Dis Sci, 46, 2440-4.
58. Manes G, Zanetti MV, Piccirillo MM, et al (2005). Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis, 37, 751-5.
59. Mao YF, Yan J (2004). Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity. World J Gastroenterology, 10, 977-84.
60. Marchildon PA, Ciota LM, Zamaniyan FZ, Peacock JS, Graham DY (1996). Evaluation of three commercial enzyme immunoassays compared with the 13C urea breath test for detection of Helicobacter pylori infection. J Clin Microbiology, 34, 1147-52.
61. Meijer BC, Thijs JC, Kleibeuker JH, van Zwet AA, Berrelkamp RJP (1997). Evaluation of eight enzyme immunoassays for detection of immunogloblin G against Helicobacter pylori. J Clinical Microbiology, 35, 292-4.
62. Michetti P KC, Kotoff K, Porta N, et al (1999). Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pyloriinfected adults. Gastroenterology, 116, 804-12.
63. Mini R, Bernardini G, Salzano AM, et al (2006). Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 833, 63-79.
64. Miwa H, Go MF, Sato N (2002). H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol, 97, 1106-12.
65. Miwa H, Akamatsu S, Tachikawa T, et al (2001). On-site diagnosis of H. pylori infection by urine. Diagn Microbiol Infect Dis, 39, 95-7.
66. Miwa H, Kikuchi S, Ohtaka K, et al (2000). Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population. Diagnostic Microbiology Infectious Disease, 36, 95-9.
67. Mobley HL (1996). The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration. Aliment Pharmacol Ther, 10, 157-64.
68. Noto JM, Gaddy JA, Lee JY, et al (2013). Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest, 123, 479-92.
69. O'Connell KL, Stalts JT (1997). Identification of mouse liver proteins on two-dimensional electrophoresis gel by matrixassociated larser desorption/ ionization mass spectrometry of in situ enzymatic digests. Electrophoresis, 18, 349-59.
70. Obata Y, Kikuchi S, Miwa H, et al (2003). Diagnostic accuracy of serological kits for Helicobacter pylori infection with the same assay system but different antigens in a Japanese patient population. J Medical Microbiology, 52, 889-92.
71. Ohtsuka Y, Shimada T, Watanabe N, et al (1997). Analysis of the vacA gene sequences among Helicobacter pylori strains isolated from Japanese patients. Gastroenterology, 112, 243.
72. Park J-W, Song J-Y, Lee S-G, et al (2006). Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter, 11, 533-43.
73. Parsons TB, Ghellamallah C, Male L, Spencer N, Grainger RS (2011). Regioselective dibromination of methyl indole-3-carboxylate and application in the synthesis of 5,6-dibromoindoles. Org Biomol Chem, 9, 5021-3.
74. Pelerito A, Oleastro M, Lopes AI, et al (2006). Evaluation of rapid test Assure Helicobacter pylori for diagnosis of H. pylori in pediatric population. J Microbiol Methods, 66, 331-5.
75. Rieder G, Fischer W, Haas R (2005). Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol, 8, 67-73.
76. Robinson K, Argent RH, Atherton JC (2007). The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol, 21, 237-59.
77. Sasidharan S, Uyub AM (2009). Antibody response to Helicobacter pylori excretory antigen and the cross reaction study. J Immunoassay Immunochem, 30, 70-81.
78. Schumann C, Triantafilou K, Rasche FM, et al (2006). Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. IJMM, 296, 223-8.
79. Shevchenko A, Wilm M, Vorm O, Mann M (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem, 68, 850-8.
80. Simor AE, Lin E, Saibil F, et al (1996). Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori. J Clin Microbiol, 34, 550-3
81. Tay Y, Mitchell H, Dong Q, et al (2009). Population structure of Helicobacter pylori among ethnic groups in Malaysia: recent acquisition of the bacterium by the Malay population. BMC Microbiology, 9, 1-13.
82. Torres J, Camorlinga-Ponce M, Perez-Perez G, Munoz L, Munoz O (2002). Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection. Clin Diagn Lab Immunol, 9, 97-100.
83. Utt M, Nilsson I, Ljungh A, Wadstrom T (2002). Identification of novel immunogenic proteins of Helicobacter pylori by proteome technology. J Immunological Methods, 259, 1-10.
84. Vaira D, Vakil N (2001). Blood, urine, stool, breath, money, and Helicobacter pylori. Gut, 48, 287-9.
85. Voland P, Weeks DL, Vaira D, Prinz C, Sachs G (2002). Specific identification of three low molecular weight membraneassociated antigens of Helicobacter pylori. Alimentary Pharmacology & Therapeutics, 16, 533-44.
86. Widmer M, de Korwin JD, Aucher P, et al (1999). Performance of native and recombinant antigens for diagnosis of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis, 18, 823-6.
87. Wu M-S, Chow L-P, Lin J-T, Chiou S-H (2008). Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: challenges and opportunities. J Gastroenterol Hepatol, 23, 1657-61.
88. Zhang C, Xu S, Xu D (2012). Risk assessment of gastric cancer caused by Helicobacter pylori using CagA sequence markers. PLoS One, 7, 36844.
89. Zhang X, Shen W, Lu Y, et al (2010). Expression of UreB and HspA of Helicobacter pylori in silkworm pupae and identification of its immunogenicity. Mol Biol Rep, 38, 3173-80.
90. Zambelli B, Turano P, Musiani F, Neyroz P, Ciurli S (2009). Zn2+-linked dimerization of UreG from Helicobacter pylori, a chaperone involved in nickel trafficking and urease activation. Proteins: Structure, Function, and Bioinformatics, 74, 222-39.
91. Zheng J, Xiao- Hong T, Huang A-L, Wang P-L (2002). A study of recombinant Protective H. pylori antigens. World J Gastroenterology, 8, 308-11.